InvestorsHub Logo

BooDog

08/14/20 9:50 AM

#2195 RE: jonsmile #2190

The company received additional communications from Nasdaq on April 14th and April 21st indicating that ultimately extended the deadline to regain compliance to December 21, 2020. From July 22, 2020 to August 4, 2020, the company’s closing bid price for ADMP has been at $1.00 per share or greater.

https://finance.yahoo.com/news/adamis-pharmaceuticals-regains-compliance-nasdaq-200500336.html

Anyway, looks like a potential momentum play into their IND.

Shorts trying to keep it under the $.

Edit: Actually, it looks like they should get their compliance letter any day. Over the $ for 10 days in a row.